Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation

por Yuan, Yuan, Wieczorek, Rosemary, Green, David L, Cook, Perry, Ballard, Harold, Araten, David J
Publicado 2009

Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)

por Lobry, Camille, Bains, Ashish, Zamechek, Leah B., Ibrahim, Sherif, Aifantis, Iannis, Araten, David J.
Publicado 2019

Application of counter-selectable marker PIGA in engineering designer deletion cell lines and characterization of CRISPR deletion efficiency

por Li, Donghui, Sun, Xiaoji, Yu, Fangzhou, Perle, Mary Ann, Araten, David, Boeke, Jef D
Publicado 2021

Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders

por Araten, David J., Belmont, H. Michael, Schaefer-Cutillo, Julia, Iyengar, Arjun, Mattoo, Aprajita, Reddy, Ramachandra
Publicado 2020

A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation

por Milam, Emily C., Martires, Kathryn J., Lo Sicco, Kristen I., Araten, David J., Franks, Andrew G.
Publicado 2019

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicente...

por Shammo, Jamile, Gajra, Ajeet, Patel, Yogesh, Tomazos, Ioannis, Kish, Jonathan, Hill, Anita, Sierra, J Rafael, Araten, David
Publicado 2022

Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria

por Kulasekararaj, Austin, Glasmacher, Axel, Liu, Peng, Szer, Jeff, Araten, David, Rauch, Geraldine, Gwaltney, Chad, Sierra, J Rafael, Lee, Jong Wook
Publicado 2022

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry

por Schrezenmeier, Hubert, Röth, Alexander, Araten, David J., Kanakura, Yuzuru, Larratt, Loree, Shammo, Jamile M., Wilson, Amanda, Shayan, Gilda, Maciejewski, Jaroslaw P.
Publicado 2020

PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY...

por Risitano, Antonio Maria, Araten, David J, Kuter, David, Patel, Bhumika J, de Latour, Régis Peffault, Dahlke, Marion, Garito, Tania, LI, Shujie, Maitra, Samopriyo, Kulasekararaj, Austin
Publicado 2023

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria

por Araten, David J, Iori, Anna Paola, Brown, Karen, Torelli, Giovanni Fernando, Barberi, Walter, Natalino, Fiammetta, De Propris, Maria Stefania, Girmenia, Corrado, Salvatori, Filippo Maria, Zelig, Orly, Foà, Robin, Luzzatto, Lucio
Publicado 2014

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia

por Evensen, Nikki A., Madhusoodhan, P. Pallavi, Meyer, Julia, Saliba, Jason, Chowdhury, Ashfiyah, Araten, David J., Nersting, Jacob, Bhatla, Teena, Vincent, Tiffaney L., Teachey, David, Hunger, Stephen P., Yang, Jun, Schmiegelow, Kjeld, Carroll, William L.
Publicado 2018